[
  {
    "uid": "39089970",
    "title": "Commentary on Efficacy and Safety of Low dose ondansetron as a prospective precision medicine to treat alcohol use disorder phenotypes.",
    "pubdate": "2024 Sep",
    "source": "Eur J Intern Med",
    "authors": [
      {
        "name": "Swift RM",
        "authtype": "Author",
        "clusterid": ""
      }
    ],
    "doi": "doi: 10.1016/j.ejim.2024.07.029",
    "summary": "This commentary discusses using low dose ondansetron as a potential precision medicine approach to treat different phenotypes of alcohol use disorder. The author is Swift RM and the commentary was published in the European Journal of Internal Medicine in September 2024. The DOI for the article is 10.1016/j.ejim.2024.07.029."
  },
  {
    "uid": "38984671",
    "title": "Trajectories of craving in the course of pharmacotherapy trials for methamphetamine use disorder.",
    "pubdate": "2024 Oct",
    "source": "Addiction",
    "authors": [
      {
        "name": "Mojtabai R",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Susukida R",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Farokhnia M",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Nguyen TQ",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Dunn KE",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Amin-Esmaeili M",
        "authtype": "Author",
        "clusterid": ""
      }
    ],
    "doi": "doi: 10.1111/add.16610",
    "summary": "This study examines the trajectories of craving in pharmacotherapy trials for methamphetamine use disorder. The authors include Mojtabai R, Susukida R, Farokhnia M, Nguyen TQ, Dunn KE, and Amin-Esmaeili M. The study was published in the journal Addiction in October 2024 with the DOI: 10.1111/add.16610."
  },
  {
    "uid": "38876929",
    "title": "Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypes.",
    "pubdate": "2024 Sep",
    "source": "Eur J Intern Med",
    "authors": [
      {
        "name": "Johnson B",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Alho H",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Addolorato G",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Lesch OM",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Chick J",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Liu L",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Schuyler V",
        "authtype": "Author",
        "clusterid": ""
      }
    ],
    "doi": "doi: 10.1016/j.ejim.2024.06.001",
    "summary": "This clinical trial investigates the use of low-dose ondansetron as a potential precision medicine treatment for alcohol use disorder endophenotypes. The study was conducted by Johnson et al. and was published in the European Journal of Internal Medicine in September 2024. The DOI for the article is 10.1016/j.ejim.2024.06.001."
  },
  {
    "uid": "38521730",
    "title": "Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment.",
    "pubdate": "2024 Sep",
    "source": "Eur J Intern Med",
    "authors": [
      {
        "name": "Addolorato G",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Alho H",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Bresciani M De Andrade P",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Lesch OM",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Liu L",
        "authtype": "Author",
        "clusterid": ""
      },
      {
        "name": "Johnson B",
        "authtype": "Author",
        "clusterid": ""
      }
    ],
    "doi": "doi: 10.1016/j.ejim.2024.03.017",
    "summary": "This clinical trial examines the safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment. The study was conducted by authors Addolorato G, Alho H, Bresciani M De Andrade P, Lesch OM, Liu L, and Johnson B and was published in the European Journal of Internal Medicine in September 2024. The DOI for the study is doi: 10.1016/j.ejim.2024.03.017."
  }
]